Clinical Trial Update: Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of Claudiximab in patients with advanced gastroesophageal cancer has completed, reporting safety findings from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Drugs mentioned

• Claudiximab

Snippet

Sponsor: Ganymed Pharmaceuticals GmbH | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED